Skip to main content

Table 6 Combination of treatment at the time of dnDSA (n = 13) and overall cg outcomes (*Fisher’s exact test p < 0.05)

From: Clinical and histological evolution after de novo donor-specific anti-human leukocyte antigen antibodies: a single centre retrospective study

N = 13

Rituximab

Plasma exchanges

IVIG

Steroid bolus and treatment reinforcement

 

yes

no

yes

no

yes

no

yes

no

No change in cg (n = 11)

5

6

4

7

4

7

6

5

Cg progression (n = 2)

1

1

2

0

1

1

2

0

  1. IVIG intravenous immunoglobulins, cg chronic glomerulopathy